The Valley Desk

NCT00294762 · Interventional trial

Erlotinib (Tarceva) as a Single Agent or Intercalated With Combination Chemotherapy in Patients With EGFR Positive NSCLC

Overall registry status Completed

Phase 2

Conditions Carcinoma, Non-Small-Cell Lung

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov